Quote: seemingly-harmless while the 13D group can jump

New Post Public Reply Private Reply Replies (3) Message Board
Goosebumps
598
Quote: seemingly-harmless

while the 13D group can jump off a cliff, i have not defended or chastised patterson for where we are at the moment, and i dont know all tha facts, no one does.


What we do know for the accusations in the filed lawsuit is that he tried to patent something he wasn’t entitled to. He was advising CYDY and had signed contract agreements that he could not patent or take any technology. But what did he do? He filed for a patent that Cytodyn had already filed for and then they found out that he filed this patent and they asked for his patent application to be revoked. This we do know from the lawsuit.

He probably came to Nader and told him you can’t sell very much of Leronlimab with me having this patent before he actually received the patent and wanted an over priced buy out of IncellDX that would enrich himself and wife over 120 million dollar. This is kind of like corporate black mail but we won’t accuse him…yet… it’s just a kind of corporate maneuver since it is speculation by me at this point but makes sense to more than just me… but many believe this to be true.

I was his biggest proponent or fan after his TEDx talk and thought the world of him. His Tedx talk locked me into this drug. Goes to show you some people’s true colors are not what they appear.

In my opinion…now he is at best a snake in the grass that tried to rob shareholders of massive amount of cash from dilution of our stock for something we as a company didn’t need and/or still don’t need.

For you to come on this board talking good about Dr. BP just make me and maybe others suspect about your motives excusing his issues as nothing and saying that any genius would do this and trying to put a positive spin on the whole situation like Dr. BP should be given a free pass at trying to screw the CYDY shareholders.

You are either not paying attention to the facts as they come to light or you are trying to spin the whole situation into something that is a lie. Dr. Bruce Patterson has let CYDY shareholders down completely and there is no way back into the hearts of the shareholders in my opinion. Dr. BP is going down in flames just like Rosenbaum and I believe every one else in his group is probably running away from the sinking ship that is the 13d group. The two of them will be left holding the bags and the costs and it will take them down and they don’t know how to cry mercy. But they might learn from this expensive lesson Cytodyn is going to teach them.

Of coarse this is partial opinion and some facts that are actually accusations in the lawsuit. Are they facts yet… can we believe them? Hell yes I believe them… it’s obvious to me he never wanted anything but self enrichment. Screw Dr. BP and the horse he rode in on… he is no friend of Cytodyn or the shareholders. To bad for Dr. BP as he had all of our hearts at one time. Doesn’t have mine now or will he ever again.


Read More: https://investorshangout.com/post/newpost/605...z72sOay2MX

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 1

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 2

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
FDI Launches 'Generation Smile' for Global Oral Health

Updated Category News Views 4

A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growing Lab Automation Industry Potential

Updated Category News Views 145

The New Landscape of Lab Automation Recent studies have shown that the global lab automation market is witnessing remarkable growth, driven by advancements in technology, changes in regulatory standards, and increasing demands for efficiency and productivity. As laboratories aim to enhance their operational effectiveness and adapt to ever-evolving scientific needs, the...

Continue Reading
Amazon's Prominence in Retail: A Comparative Analysis

Updated Category News Views 254

Amazon's Competitive Edge in Retail In today's ever-evolving retail landscape, understanding a company's place in the market is vital for both investors and those interested in the business dynamics. This analysis delves into Amazon.com Inc (NASDAQ: AMZN) and offers valuable insights into its performance compared to major competitors within the Broadline Retail sector,...

Continue Reading
Expert Insights on Bitcoin Price Dynamics Amidst Surges

Updated Category News Views 97

Expert Insights on Bitcoin Price Dynamics Bitcoin (BTC) has been in the spotlight lately, especially after it surged to an impressive peak of around $58,487 during Thursday's trading session. However, this significant rise has caught the attention of many industry experts, leading one notable crypto analyst to issue some cautious advice. Julio Moreno, the Head of Research...

Continue Reading
Key Developments in Solid-State Battery Technology by Sunrise

Updated Category News Views 228

Innovative Breakthroughs in Battery Technology In an exciting new development, Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) has taken a significant leap forward in the field of battery technology. Their subsidiary, Sunrise (Guizhou) New Energy Materials Co., Ltd., has collaborated with Songci Electromechanical Technology Co., Ltd. to create an advanced CVD fluidized bed...

Continue Reading
V2X Reports Strong First Quarter and Confirms Annual Goals

Updated Category News Views 135

V2X Reports Strong Results for First Quarter V2X, Inc. (NYSE: VVX) recently unveiled its financial results for the first quarter, demonstrating strong performance with a revenue of $1.02 billion, marking a 10% increase year-over-year, particularly in key markets. The company's commitment to its mission continues to position it effectively within the defense and technology...

Continue Reading